+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Steroid Injections Market by Treatment Type, Therapeutic Indication, End User, Molecule Type, Distribution Channel, Patient Type - Global Forecast to 2030- Product Image
Steroid Injections Market by Treatment Type, Therapeutic Indication, End User, Molecule Type, Distribution Channel, Patient Type - Global Forecast to 2030- Product Image
Sale

Steroid Injections Market by Treatment Type, Therapeutic Indication, End User, Molecule Type, Distribution Channel, Patient Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012190
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The steroid injections market offers substantial opportunities for B2B stakeholders navigating complex therapeutic, regulatory, and supply chain environments. As demand rises for precise, minimally invasive treatment options for musculoskeletal and inflammatory conditions, companies must reposition strategies to capture share and support improved care pathways.

Market Snapshot: Steroid Injections Market

The Steroid Injections Market grew from USD 4.29 billion in 2024 to USD 4.90 billion in 2025. It is expected to continue growing at a CAGR of 13.65%, reaching USD 9.26 billion by 2030.

Steriold Injections Market: Scope & Segmentation

This market research report covers a robust set of segments, regions, technologies, and patient types vital for commercial and operational stakeholders:

  • Treatment Types: Joint Injections (covering both large and small joints), Soft Tissue Injections (targeting bursa, ligament, and tendon applications), Spinal Injections (including epidural and intrathecal routes)
  • Therapeutic Indications: Addressing back pain (lower, sciatica, upper), bursitis, osteoarthritis, rheumatoid arthritis, and tendonitis
  • End Users: Ambulatory surgical centers, orthopedic clinics, pain management clinics, general and specialty hospitals
  • Molecule Types: Dexamethasone, hydrocortisone, methylprednisolone, triamcinolone
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies (including chain and independent)
  • Patient Types: Adult, geriatric, pediatric populations
  • Regions and Countries Covered: Americas (United States—with California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including prominent countries such as United Kingdom, Germany, France, and emerging regions like the Middle East and Africa), Asia-Pacific (notably China, India, Japan, Australia, and Southeast Asia)
  • Key Companies Profiled: Pfizer, Novartis, Sanofi, Bayer, Johnson & Johnson, AbbVie, Merck, Roche, Teva, Viatris
  • Technologies and Care Models: Real-time ultrasound and fluoroscopic imaging, extended-release formulations, telemedicine for pre-injection assessment and post-injection monitoring

Key Takeaways for Decision-Makers

  • Precision-guided steroid injections are becoming routine, supporting better clinical outcomes through real-time imaging and accuracy in drug delivery.
  • Advanced formulations with extended effects meet the need for longer symptom relief and fewer repeat interventions, relevant for both patient satisfaction and operational efficiency.
  • Regulatory requirements around safety and pharmacovigilance continue to shape investment in quality systems, compliance, and risk management across manufacturing and distribution.
  • Integration of digital health, such as telemedicine, enables efficient pre-procedure triage and ongoing post-injection support, building a connected care continuum.
  • Regional market distribution is influenced by local healthcare infrastructure, insurer reimbursement models, and clinical practice patterns, requiring nuanced entry and sales strategies.
  • Collaboration among device firms and pharmaceutical manufacturers is fostering bundled solutions, aligned with value-based healthcare and outcome measurement.

Tariff Impact: Navigating New Cost Pressures

The introduction of United States tariffs for 2025 has increased import duties on active pharmaceutical ingredients and critical components, raising manufacturing costs for companies relying on international sources. Many firms are reevaluating global supply chains, expanding domestic production capabilities, and optimizing logistics to control rising expenses. As a result, distributor and provider negotiations have grown more complex, focusing on cost containment and reimbursement alignment. Organizations that pivot quickly to adapt to cost fluctuations are better positioned to maintain competitiveness and secure provider relationships in tightening healthcare budgets.

Methodology & Data Sources

This analysis combines primary interviews with industry leaders, clinicians, and supply chain experts and secondary research from journals, regulatory filings, and proprietary databases. Each data point is triangulated and validated through expert consultation, ensuring reliable, evidence-based insights for business-critical decisions.

Why This Report Matters

  • Provides actionable intelligence for investment, partnership, and product development strategies within the steroid injections market.
  • Delivers segmented, region-specific insights that enable precise targeting of growth opportunities and optimization of distribution footprints.
  • Equips senior leadership with the tools to anticipate regulatory, supply chain, and reimbursement changes—minimizing risks and supporting forward-looking planning.

Conclusion

This report delivers essential visibility into the steroid injections sector’s evolving landscape, supporting informed commercial strategies. Stakeholders can utilize these insights to adapt to change, enhance operational resilience, and capture future opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Steroid Injections Market, by Treatment Type
8.1. Introduction
8.2. Joint Injections
8.2.1. Large Joints
8.2.2. Small Joints
8.3. Soft Tissue Injections
8.3.1. Bursa Injections
8.3.2. Ligament Injections
8.3.3. Tendon Injections
8.4. Spinal Injections
8.4.1. Epidural
8.4.2. Intrathecal
9. Steroid Injections Market, by Therapeutic Indication
9.1. Introduction
9.2. Back Pain
9.2.1. Lower Back Pain
9.2.2. Sciatica
9.2.3. Upper Back Pain
9.3. Bursitis
9.4. Osteoarthritis
9.5. Rheumatoid Arthritis
9.6. Tendonitis
10. Steroid Injections Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.3.1. Orthopedic Clinics
10.3.2. Pain Management Clinics
10.4. Hospitals
10.4.1. General Hospitals
10.4.2. Specialty Hospitals
11. Steroid Injections Market, by Molecule Type
11.1. Introduction
11.2. Dexamethasone
11.3. Hydrocortisone
11.4. Methylprednisolone
11.5. Triamcinolone
12. Steroid Injections Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
12.4.1. Chain Pharmacies
12.4.2. Independent Pharmacies
13. Steroid Injections Market, by Patient Type
13.1. Introduction
13.2. Adult
13.3. Geriatric
13.4. Pediatric
14. Americas Steroid Injections Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Steroid Injections Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Steroid Injections Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Novartis AG
17.3.3. Sanofi S.A.
17.3.4. Bayer AG
17.3.5. Johnson & Johnson
17.3.6. AbbVie Inc.
17.3.7. Merck & Co., Inc.
17.3.8. Roche Holding AG
17.3.9. Teva Pharmaceutical Industries Ltd.
17.3.10. Viatris Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. STEROID INJECTIONS MARKET MULTI-CURRENCY
FIGURE 2. STEROID INJECTIONS MARKET MULTI-LANGUAGE
FIGURE 3. STEROID INJECTIONS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. STEROID INJECTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSA INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LIGAMENT INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDON INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STEROID INJECTIONS MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRATHECAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LOWER BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SCIATICA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STEROID INJECTIONS MARKET SIZE, BY UPPER BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL STEROID INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDONITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL STEROID INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PAIN MANAGEMENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL STEROID INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TRIAMCINOLONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 84. CANADA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. CANADA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 86. CANADA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 87. CANADA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 88. CANADA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 89. CANADA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 90. CANADA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. CANADA STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 92. CANADA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 93. CANADA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. CANADA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 96. CANADA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 102. MEXICO STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 103. MEXICO STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. MEXICO STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 105. MEXICO STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. MEXICO STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 109. MEXICO STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 163. GERMANY STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 164. GERMANY STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 165. GERMANY STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 166. GERMANY STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 167. GERMANY STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 168. GERMANY STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 169. GERMANY STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. GERMANY STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 171. GERMANY STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. GERMANY STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 173. GERMANY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. GERMANY STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 175. GERMANY STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 179. FRANCE STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 180. FRANCE STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 181. FRANCE STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 182. FRANCE STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. FRANCE STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 184. FRANCE STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 185. FRANCE STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 186. FRANCE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. FRANCE STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 188. FRANCE STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 202. ITALY STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 203. ITALY STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 204. ITALY STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 205. ITALY STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 206. ITALY STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 207. ITALY STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 208. ITALY STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. ITALY STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 210. ITALY STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. ITALY STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 212. ITALY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. ITALY STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 214. ITALY STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 215. SPAIN STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 216. SPAIN STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 217. SPAIN STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 218. SPAIN STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 219. SPAIN STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 220. SPAIN STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 221. SPAIN STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SPAIN STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 223. SPAIN STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. SPAIN STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 225. SPAIN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. SPAIN STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 227. SPAIN STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 267. DENMARK STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 268. DENMARK STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 269. DENMARK STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 270. DENMARK STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 271. DENMARK STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 272. DENMARK STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 273. DENMARK STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. DENMARK STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 275. DENMARK STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 276. DENMARK STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 277. DENMARK STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. DENMARK STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 279. DENMARK STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 293. QATAR STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 294. QATAR STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 295. QATAR STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 296. QATAR STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 297. QATAR STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 298. QATAR STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 299. QATAR STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. QATAR STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 301. QATAR STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 302. QATAR STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 303. QATAR STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. QATAR STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 305. QATAR STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 306. FINLAND STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 307. FINLAND STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 308. FINLAND STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 309. FINLAND STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 310. FINLAND STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 311. FINLAND STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 312. FINLAND STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. FINLAND STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 314. FINLAND STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 315. FINLAND STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 316. FINLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. FINLAND STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 318. FINLAND STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. SWEDEN STEROID INJECTIONS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 327. SWEDEN STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 328. SWEDEN STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 329. SWEDEN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 331. SWEDEN STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2030 (USD MILLION)
TABLE 337. NIGERIA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2030 (USD MILLION)
TABLE 338. NIGERIA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. NIGERIA STEROID INJECTIONS MARKET SIZE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Steroid Injections market report include:
  • Pfizer Inc.
  • Novartis AG
  • Sanofi S.A.
  • Bayer AG
  • Johnson & Johnson
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Roche Holding AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.9 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.26 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Joint Pain Injections Market Report 2025 - Product Image

Joint Pain Injections Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Joint Pain Injections Market by Molecule Type, Indication, Route Of Administration, End User, Distribution Channel, Patient Age Group - Global Forecast to 2030 - Product Image

Joint Pain Injections Market by Molecule Type, Indication, Route Of Administration, End User, Distribution Channel, Patient Age Group - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Ropivacaine Hydrochloride & Sodium Chloride Injection Market by Application Type, Formulation, End User, Dosage Strength, Distribution Channel - Global Forecast to 2030 - Product Image

Ropivacaine Hydrochloride & Sodium Chloride Injection Market by Application Type, Formulation, End User, Dosage Strength, Distribution Channel - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Sacroiliac Joint Fusion Injections and RF Ablation Market Size, Share & Trends Analysis Report by Indication (Degenerative Sacroiliitis, Sacral Disruption), Type (Diagnosis), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Sacroiliac Joint Fusion Injections and RF Ablation Market Size, Share & Trends Analysis Report by Indication (Degenerative Sacroiliitis, Sacral Disruption), Type (Diagnosis), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From

About the Steroid Injections Market

The steroid injections market is a subset of the broader infusions and injectables sector, focusing on products that deliver steroids directly into the body tissues, including joints, muscles, and the spine. Steroids, which are synthetic drugs that closely resemble cortisol, a hormone that the body produces naturally, are used to reduce inflammation and suppress the immune system. They are commonly prescribed for a range of conditions including arthritis, back pain, and various inflammatory diseases. The market comprises a variety of steroid types, including cortisone, methylprednisolone, and triamcinolone, among others. These injections are often administered in outpatient settings like clinics and hospitals by healthcare professionals, including doctors and nurses, who are skilled in performing these procedures. The sector is influenced by factors such as the prevalence of chronic diseases, advancements in drug formulations, and improvements in administration techniques, providing patients with pain management and symptomatic relief options. Some notable players in the steroid injections market include Pfizer Inc., Novartis AG, Merck & Co., Inc., Johnson & Johnson, and Bristol-Myers Squibb Company. These companies are engaged in the production and distribution of steroid injectables and continuously invest in research and development to improve the efficacy and safety profiles of their products. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.